Serum Monocyte Chemotactic Protein-1 and Nitric Oxide in Cutaneous Leishmaniasis Patients before and after Treatment with Glucantime

Serum Monocyte Chemotactic Protein-1 and Nitric Oxide in Cutaneous Leishmaniasis Patients before and after Treatment with Glucantime

Background: It is necessary to recognize the role and function of immune system in wound healing, control, and treatment of cutaneous leishmaniasis (CL). According to the published papers, immune system factors such of monocyte chemotactic protein-1 (MCP1) and nitric oxide (NO) have an impact on wou...

Full description

Bibliographic Details
Main Authors:	Faezeh Mohammadi, Manizheh Narimani, Nafise Esmaeil, Hossein Yousefi, Abasali Eskandarian, Seyed Hossein Hejazi
Format:	Article
Language:	fas
Published:	Vesnu Publications 2012-03-01
Series:	مجله دانشکده پزشکی اصفهان
Online Access:	http://jims.mui.ac.ir/index.php/jims/article/view/1592

Similar Items

Topical Fluconazole Combined with Local Glucantime Injection Compared with Local Glucantime Injections in Treatment of Leishmaniasis
by: Mohammad Ali Nilforooshzadeh, et al.
Published: (2011-03-01)

Treatment Outcome of the Drug-resistant Zoonotic Cutaneous Leishmaniasis by Glucantime
by: Simindokht Soleimanifard, et al.
Published: (2017-01-01)

A Comparetaive Study on Glucantime and Oral Terbinafine along with Systemic Glucantime on Cutaneous Leishmaniasis
by: Saba Ebrahimian, et al.
Published: (2011-03-01)

Tc1 Cells Percentage in Patients with Cutaneous Leishmaniasis before and after Treatment with Glucantime
by: M Mohajery, et al.
Published: (2007-05-01)

Tc1 Cells Percentage in Patients with Cutaneous Leishmaniasis before and after Treatment with Glucantime
by: M Mohajery, et al.
Published: (2007-03-01)

Identification and Isolation of the Cause of Cutaneous Leishmaniasis in Is-fahan Using ITS-PCR Method
by: Faezeh Mohammadi, et al.
Published: (2012-03-01)

Efficacy of glucantime for treatment of cutaneous leishmaniasis in Central Iran
by: Mahmoud Mohammadzadeh, et al.
Published: (2013-04-01)

The Skin Side Effects of Topical Glucantime in Patients with Cutaneous Leishmaniasis
by: Mohammad Ali Nilforoushzadeh, et al.
Published: (2015-08-01)

Comparing the Effects of Topical Miltefosine and Glucantime in Treatment of Cutaneous Leishmaniasis
by: Ali Asilian, et al.
Published: (2014-03-01)

Comparative study of cryotherapy and interlesional Glucantime in the treatment of cutaneous leishmaniasis
by: Akhyani M
Published: (1997-07-01)

A Comparison between the Effects of Glucantime, Topical Trichloroacetic Acid 50% plus Glucantime, and Fractional Laser plus Glucantime on Cutaneous Leishmaniasis Lesions
by: Mohammad Ali Nilforoushzadeh, et al.
Published: (2013-03-01)

Comparison between intralesional glucantime injection and cryotherapy in papular cutaneous leishmaniasis
by: Yazdanpanah MJ, et al.
Published: (2006-10-01)

Decreased effect of glucantime in cutaneous leishmaniasis complicated with secondary bacterial infection
by: G Sadeghian, et al.
Published: (2011-01-01)

Treatment of cutaneous leishmaniasis: cassia fistula fruit gel- intralesional glucantime Vs. placebo gel- intralesional glucantime combination
by: Jaffary F, et al.
Published: (2010-01-01)

A Comparison between the Effects of Glucantime, Topical Trichloroacetic Acid 50% plus Glucantime, and Fractional Carbon Dioxide Laser plus Glucantime on Cutaneous Leishmaniasis Lesions
by: Fariba Jaffary, et al.
Published: (2016-01-01)

The Evaluation of Intralesional Glucantime and Cryotherapy plus Intralesional Glucantime Therapeutic Efficacy on Zoonotic Cutaneous Leishmaniasis: A Randomized Clinical Trial
by: Abedin Saghafipour, et al.
Published: (2017-12-01)

Immunopathology of american cutaneous leishmaniasis. Modulation of MHC class II gene products by Keratinocytes before and after glucantime therapy
by: Claude Pirmez, et al.
Published: (1990-06-01)

The Effect of Local Allergic Reaction to Intralesional Glucantime on Recovery Course of Cutaneous Leishmaniasis
by: Saman Afkhami-Ardakani, et al.
Published: (2020-04-01)

Clinical and laboratory evaluation of cured and non-cured patients with cutaneous leishmaniasis treated by Glucantime
by: F Ezatkhah, et al.
Published: (2019-01-01)

Effect of topical honey application along with intralesional injection of glucantime in the treatment of cutaneous leishmaniasis
by: Moradi Shahram, et al.
Published: (2007-04-01)

The Additive Effect of Topical Ciprofloxacin 2% on Intralesional Glucantime Injection in Treatment of Cutaneous Leishmaniasis
by: Mohamadjavad Yazdanpanah, et al.
Published: (2020-06-01)

Therapeutic Potential of Green Synthesized Copper Nanoparticles Alone or Combined with Meglumine Antimoniate (Glucantime<sup>®</sup>) in Cutaneous Leishmaniasis
by: Aishah E. Albalawi, et al.
Published: (2021-03-01)

Efficacy of miltefosine compared with glucantime for the treatment of cutaneous leishmaniasis: a systematic review and meta-analysis
by: Sohrab Iranpour, et al.
Published: (2019-03-01)

Unresponsiveness to Glucantime treatment in Iranian cutaneous leishmaniasis due to drug-resistant Leishmania tropica parasites.
by: Ramtin Hadighi, et al.
Published: (2006-05-01)

Comparison of intralesional two percent zinc sulfate and glucantime injection in treatment of acute cutaneous leishmaniasis
by: Masoud Maleki, et al.
Published: (2012-01-01)

PERILESIONAL INFILTRATION OF GLUCANTIME AND LIDOCAINE FOR TREATMENT OF LEISHMANIASIS
by: Reyes Alirio Torres, et al.
Published: (2000-05-01)

The Efficacy of Achillea Millefolium Topical Gel Along with Intralesional Injection of Glucantime in the Treatment of Acute Cutaneous Leishmaniasis
by: Fariba Jaffary, et al.
Published: (2012-03-01)

Efficacy of Topical Liposomal Amphotericin B versus Intralesional Meglumine Antimoniate (Glucantime) in the Treatment of Cutaneous Leishmaniasis
by: Pouran Layegh, et al.
Published: (2011-01-01)

A Comparison of the Effects of Topical Injection of Glucantime Plus Glycolic Acid 70% and Salicylic Acid 20% with Topical Injection of Glucantime Alone in the Treatment of Acute Cutaneous Leishmaniasis
by: Mohammad Ali Nilforoushzadeh, et al.
Published: (2017-04-01)

The efficacy of Achilles millefolium topical gel along with intralesional injection of glucantime in the treatment of acute cutaneous leishmaniasis major
by: Fariba Jaffary, et al.
Published: (2014-01-01)

The Role of Nitric Oxide and Reactive Oxygen Species in the Killing of Leishmania braziliensis by Monocytes from Patients with Cutaneous Leishmaniasis.
by: Pedro Paulo Carneiro, et al.
Published: (2016-01-01)

Therapeutic Effect of Sodium Selenite and Zinc Sulphate as Supplementary with Meglumine Antimoniate( Glucantime®) Against Cutaneous Leishmaniasis In BALB/C Mice
by: M Mohebali, et al.
Published: (2010-09-01)

Treatment of Glucantim™-Resistant Cutaneous Leishmaniasis Using Combination Therapy of Allopurinol and Trichloroacetic Acid (TCA) 50%; Report of Three Cases
by: Giti Sadeghian, et al.
Published: (2017-01-01)

Endothelin-1 Stimulates Monocytes in vitro to Release Chemotactic Activity Identified as Interleukin-8 and Monocyte Chemotactic Protein-1
by: E. Helset, et al.
Published: (1994-01-01)

Preparation and Evaluation of Clinical Effects of Glucantime Gel Mask
by: Sayed Abolfazl Mostafavi, et al.
Published: (2013-06-01)

Interferon-γ Stimulates Monocyte Chemotactic Protein-1 Expression by Monocytes
by: J. M. Liebler, et al.
Published: (1994-01-01)

Therapeutic Effect of Sodium Selenite and Zinc Sulphate as Sup-plementary with Meglumine Antimoniate( Glucantime®) Against Cutaneous Leishmaniasis In BALB/C Mice
by: F Zamani Sorkhroodi, et al.
Published: (2010-09-01)

Reactive Oxygen Species and Nitric Oxide in Cutaneous Leishmaniasis
by: Maria Fátima Horta, et al.
Published: (2012-01-01)

Expansion of <FONT FACE=Symbol>gd</font><FONT FACE=Symbol> </font>T cells in patients infected with cutaneous leishmaniasis with and without glucantime therapy
by: Haideh Darabi, et al.

Intrarectal glucantime
by: Philip D. Marsden
Published: (1996-06-01)

Cannot write session to /tmp/vufind_sessions/sess_4io0s5799n1580t4olu5nu38jv